Drug Profile
Gemigliptin/rosuvastatin - LG Chem
Alternative Names: Rosuvastatin/gemigliptin; ZemiStatinLatest Information Update: 12 Mar 2019
Price :
$50
*
At a glance
- Originator LG Life Sciences
- Developer LG Chem
- Class Antihyperglycaemics; Fluorobenzenes; Piperidines; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Dyslipidaemias; Type 2 diabetes mellitus
Most Recent Events
- 08 Mar 2019 LG Chem plans a phase I trial in healthy volunteers (NCT03867942)
- 11 Oct 2018 Chemical structure information added
- 09 Jun 2017 Efficacy and adverse events data from a phase III trial in Type-2 diabetes mellitus and Dyslipidaemias presented at the 77th Annual Scientific Sessions of the American Diabetes Association (ADA-2017)